Dupuytren’s contracture picked up the nickname “Viking disease” because it overwhelmingly affects people of Northern European descent, and the popular theory is that Norse seafarers spread the genetic predisposition across the regions they settled during the Viking Age. The condition causes connective tissue in the palm to thicken and tighten, gradually curling one or more fingers toward the palm until they can no longer straighten. The name stuck because the geographic footprint of the disease maps remarkably well onto historical Viking migration routes, from Scandinavia through Britain, Iceland, and Normandy. But the genetics behind the nickname turn out to be far stranger than the folklore suggests.
The Viking Migration Theory
The formal name comes from Baron Guillaume Dupuytren, the French surgeon who published a detailed description of the condition’s anatomy and surgical treatment in the 1830s. But “Viking disease” is the term many patients hear first, and it reflects a real epidemiological pattern: the condition is most common in Scandinavia, the British Isles, and other parts of Northern Europe that experienced significant Norse settlement between roughly the 8th and 11th centuries.1Europe PMC. The Vikings and Baron Dupuytren’s disease Rates drop as you move south and east across Europe, and the disease is rare in sub-Saharan African and East Asian populations.
The idea is intuitive: Vikings sailed, raided, traded, and intermarried across a wide swath of territory, and wherever they settled in large numbers, the local gene pool picked up whatever variants predispose people to Dupuytren’s. It is a clean story. The reality, as a 2023 study revealed, is considerably more interesting.
The Neanderthal Connection
A large genetic analysis published in Molecular Biology and Evolution found that three of the most significant genetic risk loci for Dupuytren’s disease carry DNA inherited not from Viking ancestors but from Neanderthals. Researchers meta-analyzed data from over 7,800 cases and more than 645,000 controls and identified 61 genome-wide significant variants linked to the condition. Of those 61, three harbored alleles of Neanderthal origin, including the second and third most strongly associated loci.2Molecular Biology and Evolution. Major Genetic Risk Factors for Dupuytren’s Disease Are Inherited From Neandertals All three Neanderthal-derived variants were associated with increased risk.
This finding reframes the “Viking disease” label in an unexpected way. The genetic roots of the condition are not a few centuries old but tens of thousands of years old, dating back to interbreeding between modern humans and Neanderthals after humans migrated out of Africa. Because people of African ancestry carry very little Neanderthal DNA, the near-absence of Dupuytren’s in African populations makes more sense through this lens. The “Viking” pattern is real, but it is better understood as a signature of archaic human DNA that concentrated in Northern European populations over millennia rather than something the Norse carried around in their longboats.3PubMed Central. Major Genetic Risk Factors for Dupuytren’s Disease Are Inherited From Neandertals
How Genetics Shape Who Gets It
Beyond the Neanderthal variants, the overall genetic architecture of Dupuytren’s disease helps explain why some ethnic groups are hit harder than others. Researchers constructed a genetic risk score using 26 known Dupuytren-associated variants and tested whether the average score in different populations correlated with known disease prevalence. It did: the genetic risk score explained about 36% of the variance in prevalence between populations, and the correlation was statistically significant.4European Journal of Human Genetics. Ethnic differences in prevalence of Dupuytren disease can partly be explained by known genetic risk variants
That 36% is meaningful but not the whole story. It means genetics account for a large chunk of why Scandinavians get Dupuytren’s more than, say, Japanese or Nigerian populations, but other factors also contribute. These include environmental exposures and lifestyle variables that vary across populations. The remaining unexplained variance may also reflect genetic variants that have not yet been identified. Still, the overall picture is clear: ancestry is the single largest predictor of whether someone develops this condition.
What Actually Happens in the Hand
Dupuytren’s starts in the palmar fascia, a sheet of connective tissue that sits just beneath the skin of the palm. In affected people, cells in this tissue begin to overproduce collagen and proliferate abnormally, forming lumps called nodules. Over months or years, these nodules can mature into thick cords of tissue that run from the palm into the fingers, shortening progressively and pulling the fingers into a bent position. The ring finger and little finger are the most commonly affected.
At the molecular level, the process is driven by overactive fibroblasts, the cells responsible for making and maintaining connective tissue. A growth factor called TGF-beta promotes fibroblast activity and collagen buildup.5PubMed Central. Dupuytren’s Contracture: A Review of the Literature But the deeper genetic story involves a cell-signaling system called the Wnt pathway. A major study found that six of nine gene loci most strongly linked to Dupuytren’s harbor genes in the Wnt-signaling pathway, suggesting that disruptions in this system are central to the disease process.6PubMed. Wnt signaling and Dupuytren’s disease Follow-up work examining tissue from Dupuytren’s nodules found that dozens of Wnt-related genes were dysregulated, with the pathway’s natural braking mechanisms effectively shut down while the accelerators stayed active.7PubMed. Wnt pathway in Dupuytren disease: connecting profibrotic signals
In plain terms, the cells that maintain palm tissue lose the ability to regulate themselves. They keep building collagen when they should stop, and the tissue gradually contracts like a slowly tightening rope.
Who Gets It and When
Dupuytren’s is predominantly a condition of older men. A large population-based study found that overall prevalence was roughly 0.67%, but the rate in men was nearly double that in women. The highest prevalence fell in the 75-to-85 age bracket for both sexes, and the peak incidence occurred between 65 and 75.8PubMed Central. Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis The condition does occur in women, though typically later in life and often with milder disease.
These prevalence numbers understate how common the condition is in Northern European men specifically. Studies from Norway and Iceland have historically found prevalence rates many times higher than the general population figures from mixed-ancestry countries. If you are a man over 60 with Scandinavian, British, or Irish heritage, your chances are meaningfully elevated.
Risk Factors Beyond Ancestry
Genetics loads the gun, but several lifestyle and environmental factors seem to pull the trigger. The evidence for each varies in strength.
Alcohol consumption has one of the stronger associations. A Mendelian randomization study, a design that uses genetic variants as stand-ins for exposures to test for causal links, found that drinks per week were causally related to Dupuytren’s, with roughly a threefold increase in odds. Interestingly, the same study found no causal link between smoking and the disease, despite older observational research suggesting one.9PubMed Central. Smoking, alcohol consumption and risk of Dupuytren’s disease: a Mendelian randomization study
Diabetes is another well-documented risk factor. A study examining disease prevalence across age groups found that people with diabetes had significantly higher rates of Dupuytren’s than the general population, regardless of age group.10PubMed Central. The prevalence of Dupuytren’s disease in patients with diabetes mellitus The mechanism is not fully understood, but chronically elevated blood sugar may accelerate abnormal collagen formation in connective tissue.
Manual labor and vibration exposure round out the picture. A surveillance study found that heavy manual work without vibration exposure roughly quadrupled the odds of Dupuytren’s after adjusting for age and diabetes. Using vibrating tools raised the odds fivefold, and workers with more than ten years of vibration exposure had about a tenfold increase in odds.11PubMed Central. Heavy manual work, exposure to vibration and Dupuytren’s disease? Results of a surveillance program for musculoskeletal disorders A separate systematic review and meta-analysis confirmed the association between hand-arm vibration exposure and Dupuytren’s, though the authors noted that the mostly cross-sectional study designs limit firm conclusions about causation.12PubMed. Exposure to hand-arm vibrations in the workplace and the occurrence of hand-arm vibration syndrome, Dupuytren’s contracture, and hypothenar hammer syndrome: a systematic review and meta-analysis Another population study found the condition was more common in men who performed heavy lifting or digging at work, but found no link with computer keyboard use.13PubMed Central. Dupuytren’s contracture and occupational exposure to hand-transmitted vibration
The occupational angle adds a layer to the Viking nickname. Norse culture was heavily manual, with shipbuilding, rowing, and farmwork all involving repetitive hand strain. Whether that contributed to the condition’s prevalence in Viking populations is pure speculation, but it is not hard to imagine that environmental triggers interacted with genetic susceptibility in a population already predisposed.
It Often Does Not Travel Alone
Dupuytren’s belongs to a family of fibrotic conditions that can affect different parts of the body. Ledderhose disease involves the same kind of abnormal tissue growth in the sole of the foot. Peyronie’s disease involves fibrosis in the penis. All three share the same underlying problem: fibroblasts proliferating out of control and depositing excess collagen where it does not belong.14PubMed. Patients with Dupuytren’s Contracture, Ledderhose Disease, and Peyronie’s Disease are at higher risk of arthrofibrosis following total knee arthroplasty
A study of 730 men with Dupuytren’s found that roughly 8% to 9% also had Peyronie’s disease, and between 16% and 22% had Ledderhose disease, depending on whether the estimate came from a surgeon’s exam or the patient’s self-report.15PubMed. Prevalence of Peyronie and Ledderhose Diseases in a Series of 730 Patients with Dupuytren Disease When doctors refer to “Dupuytren’s diathesis,” they mean a patient who has an aggressive form of the disease often accompanied by one or more of these related conditions, bilateral hand involvement, or early onset. People with a strong diathesis tend to have more recurrence after treatment.
Treatment Options and Recurrence
There is no cure for Dupuytren’s disease, and treatment is generally reserved for when the contracture interferes with daily function. The classic “tabletop test” is a rough guide: if you cannot lay your hand flat on a table, you have enough contracture to consider intervention.
Three main approaches exist. Limited fasciectomy is surgery to remove the affected tissue. Needle aponeurotomy uses a needle inserted through the skin to puncture and weaken the cord until it can be snapped straight. Collagenase injection uses an enzyme to dissolve the cord, which is then snapped during a follow-up visit. In a randomized trial, collagenase improved joint range of motion from about 44 degrees to 81 degrees, compared with almost no change with placebo.16PubMed. Injectable Collagenase Clostridium Histolyticum for Dupuytren’s Contracture
The trade-off between these approaches is invasiveness versus durability. A systematic review of prospective data with two to seven years of follow-up found that limited fasciectomy had the lowest recurrence rate at about 17%. Collagenase injection recurred in roughly a third of treated joints, and needle aponeurotomy recurred in nearly half.17PubMed Central. Likelihood of Dupuytren Contracture Recurrence After Limited Fasciectomy, Needle Aponeurotomy or Collagenase Clostridium histolyticum Fasciectomy involves more recovery time and surgical risk but buys significantly longer-lasting results. Joints in the middle of the finger were much more likely to recur after any treatment than joints at the base of the finger.
For early-stage disease, when there are nodules and perhaps mild contracture but no functional limitation, radiation therapy has been explored as a way to slow or halt progression. A systematic review found that when hands with early-stage disease received radiation at a typical dose of about 30 Gy, most remained stable, though regression rates varied widely and progression still occurred in a subset of patients. When progression did happen after radiation, surgery still worked normally without wound-healing problems.
What Happens After Treatment
Recovery after Dupuytren’s treatment involves hand therapy to regain motion and strength. A common question is whether wearing a night splint after surgery helps maintain the correction. The evidence is surprisingly clear: routine splinting does not appear to add benefit beyond hand therapy alone. A randomized controlled trial comparing patients who were all splinted after fasciectomy with patients who received therapy and were splinted only when contractures reappeared found no difference in disability or range of motion between groups.18PubMed Central. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren’s contracture: a pragmatic, multi-centre, randomised controlled trial A systematic review and meta-analysis similarly concluded that splinting offered no added functional benefit to hand therapy alone, though splints might still be useful for individual patients who develop an extension deficit after surgery.19Journal of Hand and Microsurgery. Comparison of Hand Therapy with or without Splinting Postfasciectomy for Dupuytren’s Contracture: Systematic Review and Meta-Analysis
Given the added cost of custom splints and the inconvenience of wearing them for months, the recommendation from the best available evidence is to skip routine night splinting and reserve it for patients whose fingers start tightening up again postoperatively.20PubMed Central. Clinical effectiveness of post-operative splinting after surgical release of Dupuytren’s contracture: a systematic review This is a good example of a longstanding clinical habit, splinting everyone automatically, that the evidence does not support.
Living With a “Viking” Diagnosis
If you have been told you have Dupuytren’s, the most important thing to understand is that having the condition does not mean you will inevitably need surgery. Many people develop nodules in their palms that never progress to contracture. Among those who do develop contracture, progression is often slow, measured in years rather than months. Monitoring and waiting until function is actually affected remains a reasonable strategy for many patients.
The nickname “Viking disease” persists because it is catchy and because it captures a real truth about who gets the condition most often. But the genetic trail now runs much deeper than the Viking Age, reaching back to interbreeding with Neanderthals tens of thousands of years ago. And while ancestry is the biggest single risk factor, alcohol intake, diabetes, and years spent doing heavy manual work or using vibrating tools all meaningfully increase the odds. For people with Northern European heritage who notice a lump forming in their palm, especially men past middle age, it is worth getting an evaluation. Not because it is an emergency, but because knowing what you are dealing with helps you plan whether and when to act.